OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
+9.96%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$1.06B
AUM Growth
+$1.06B
(+59%)
Cap. Flow
+$338M
Cap. Flow
% of AUM
31.93%
Top 10 Holdings %
Top 10 Hldgs %
89.14%
Holding
24
New
5
Increased
–
Reduced
6
Closed
–
Top Buys
1 |
Nuvation Bio
NUVB
|
$295M |
2 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$63.5M |
3 |
Sana Biotechnology
SANA
|
$28.2M |
4 |
OMEG
Omega Alpha SPAC Class A Ordinary Shares
OMEG
|
$5M |
5 |
Immunocore
IMCR
|
$2.19M |
Top Sells
1 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$41.1M |
2 |
ESSA Pharma
EPIX
|
$10.7M |
3 |
Replimune Group
REPL
|
$2.03M |
4 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$1.35M |
5 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
$611K |
Sector Composition
1 | Healthcare | 99.53% |
2 | Financials | 0.47% |